Long-term intravenous administration of activated autologous lymphocytes for cancer patients does not induce antinuclear antibody and rheumatoid factor.
Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Kohtaro Yamamoto, Yasuyuki Kuroiwa, Norio Shimizu(Tokyo Medical and Dental University), Kenji Ogawa, Kazuhiko Yoshimatsu(Tokyo Women's Medical University Adachi Medical Center), Ayari Kitayama, Takeshi Shimakawa, Teruaki Sekine
PubMed
September 23, 2004
Cited by 7
Related Papers
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system
|Cancer Science|2014|238
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies
|Leukemia|2009|197
Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212
|European Journal of Surgical Oncology|2016|138
Molecular and Virological Evidence of Viral Activation From Chromosomally Integrated Human Herpesvirus 6A in a Patient With X-Linked Severe Combined Immunodeficiency
|Clinical Infectious Diseases|2014|137
Learning curve for robotic-assisted surgery for rectal cancer: use of the cumulative sum method
|Surgical Endoscopy|2014|132